Safety and surveillance trials are a legal requirement throughout a drug’s lifetime, thus forming a crucial component of all post-marketing studies. The use of innovative mHealth approaches can support the comprehensive monitoring of drugs to ensure their ongoing safety and efficacy.
In addition, and driven by the increasing cost burden of healthcare, both clinical and cost effectiveness criteria have become vital measures for receiving market access or reimbursement for new drugs, devices and therapies. Vodafone mHealth Solutions can support patient retention and data capture in studies supporting health economics and outcomes research.
Driven by the increasing cost burden of healthcare, both clinical as well as cost effectiveness criteria have become vital measures for receiving market access or reimbursement of new drugs, devices and therapies. Vodafone supported a big pharmaceutical customer with a resource utilisation study amongst 300 epileptic patients across three countries.
Keep up to date  |
 |
 |
 |
 |
Contact usIf you are interested in any of our products or services or simply have a question you'd like to ask, do get in touch.
© 2012 Vodafone Global Enterprise Limited. Registered Office: Vodafone House, The Connection, Newbury, RG14 2FN. Registered in England No 2844851. 
